Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
4
×
texas top stories
wisconsin blog main
wisconsin top stories
alzheimer's disease
biogen
clinical trials
deals
eli lilly
johnson & johnson
medicaid
medicare
pfizer
spinal muscular atrophy
startups
affordable care act
aldeyra therapeutics
alexion pharmaceuticals
What
alzheimer’s
4
×
bio
4
×
roundup
drug
prices
week
aducanumab
amyloid
angst
annual
assessed
attention
bagged
billions
biogen
biogen’s
biotech
brammer
communities
companies
conference
congress
democrats
different
divided
effects
elections
esmo
europe
fail
failure
fallout
felt
gene
germany
hosted
increases
investment
latest
losses
Language
Current search:
bio
×
alzheimer’s
×
" texas blog main "
×
@xconomy.com
5 years ago
Bio Roundup: Amyloid Angst, NASH News, Brammer Bagged & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
Bio Roundup: Midterm Fallout, Alzheimer’s Search, Postpartum Panel
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More